|
WO1998032467A2
(en)
*
|
1997-01-24 |
1998-07-30 |
Antivirals, Inc. |
Method and conjugate for treating h. pylori infection
|
|
WO1998035703A2
(en)
*
|
1997-02-14 |
1998-08-20 |
The Salk Institute For Biological Studies |
Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents
|
|
ATE251913T1
(de)
|
1997-05-21 |
2003-11-15 |
Univ Leland Stanford Junior |
Zusammensetzung und verfahren zur verzögerung des transports durch biologische membranen
|
|
US6958148B1
(en)
|
1998-01-20 |
2005-10-25 |
Pericor Science, Inc. |
Linkage of agents to body tissue using microparticles and transglutaminase
|
|
US6919076B1
(en)
|
1998-01-20 |
2005-07-19 |
Pericor Science, Inc. |
Conjugates of agents and transglutaminase substrate linking molecules
|
|
US20020064520A1
(en)
*
|
1999-08-19 |
2002-05-30 |
Yanina Rozenberg |
Targeted artificial gene delivery
|
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
|
JP2003507438A
(ja)
|
1999-08-24 |
2003-02-25 |
セルゲイト， インコーポレイテッド |
オリゴアルギニン部分を使用する上皮組織を横切るおよび上皮組織内への薬物送達の増強
|
|
US7229961B2
(en)
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
|
WO2002004479A1
(en)
|
2000-07-06 |
2002-01-17 |
Avi Biopharma, Inc. |
TRANSFORMING GROWTH FACTOR BETA (TGF-β) BLOCKING AGENT-TREATED STEM CELL COMPOSITION AND METHOD
|
|
US7807780B2
(en)
|
2000-07-21 |
2010-10-05 |
Revance Therapeutics, Inc. |
Multi-component biological transport systems
|
|
JP2004523480A
(ja)
*
|
2000-08-22 |
2004-08-05 |
ニュー リバー ファーマシューティカルズ， インコーポレイテッド |
活性作用物質送達系ならびに活性作用物質の保護および投与方法
|
|
JP2006516948A
(ja)
*
|
2000-11-14 |
2006-07-13 |
ニュー リバー ファーマシューティカルズ インコーポレイテッド |
硫酸アバカビルを含有する新規な薬剤化合物および同化合物の製造ならびに使用方法
|
|
EP2316469A1
(en)
*
|
2002-02-22 |
2011-05-04 |
Shire LLC |
Delivery system and methods for protecting and administering dextroamphetamine
|
|
EP1583562B1
(en)
|
2003-01-06 |
2011-06-15 |
Angiochem Inc. |
Angiopep-1, related compounds, and uses thereof
|
|
WO2005072527A2
(en)
|
2004-01-23 |
2005-08-11 |
Avi Biopharma, Inc. |
Antisense oligomers and methods for inducing immune tolerance and immunosuppression
|
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
CN101083907B
(zh)
|
2004-03-03 |
2012-10-10 |
雷文斯治疗公司 |
用于局部诊断剂和治疗剂运输的组合物和方法
|
|
US8314072B2
(en)
|
2004-07-02 |
2012-11-20 |
Avi Biopharma, Inc. |
Antisense antibacterial method and compound
|
|
CA2596506C
(en)
|
2005-02-09 |
2021-04-06 |
Avi Biopharma, Inc. |
Antisense composition and method for treating muscle atrophy
|
|
PL2360258T3
(pl)
|
2005-02-18 |
2015-03-31 |
Angiochem Inc |
Polipeptydy aprotyniny do transportowania związków przez barierę krew-mózg
|
|
RU2007136617A
(ru)
|
2005-03-03 |
2009-04-10 |
Риванс Терапьютикс, Инк. (Us) |
Композиция и способ для местного применения и чрезкожного введения олигопептида
|
|
AU2006218431B2
(en)
|
2005-03-03 |
2012-12-06 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
US8067571B2
(en)
|
2005-07-13 |
2011-11-29 |
Avi Biopharma, Inc. |
Antibacterial antisense oligonucleotide and method
|
|
AU2006267051B2
(en)
|
2005-07-13 |
2013-03-07 |
Sarepta Therapeutics, Inc. |
Antisense antibacterial method and compound
|
|
ES2424242T3
(es)
|
2005-07-15 |
2013-09-30 |
Angiochem Inc. |
Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos
|
|
US8501704B2
(en)
|
2005-11-08 |
2013-08-06 |
Sarepta Therapeutics, Inc. |
Immunosuppression compound and treatment method
|
|
EP1935434A1
(en)
*
|
2006-12-19 |
2008-06-25 |
Novosom AG |
Construction and use of transfection enhancer elements
|
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
|
AU2009225590B2
(en)
|
2008-03-20 |
2013-05-02 |
Stephen H. Bartelmez |
Enhancing vessel lesion homing and repair potential of stem cells
|
|
EP2143726A1
(en)
*
|
2008-07-11 |
2010-01-13 |
Novosom AG |
Nucleic acid comprising zwitterionic nucleotides
|
|
MX2011004017A
(es)
|
2008-10-15 |
2011-06-24 |
Angiochem Inc |
Conjugados de agonistas glp-1 y usos de los mismos.
|
|
AU2009322043A1
(en)
|
2008-12-05 |
2011-07-07 |
Angiochem Inc. |
Conjugates of neurotensin or neurotensin analogs and uses thereof
|
|
AU2009335740B2
(en)
*
|
2008-12-17 |
2016-04-21 |
Sarepta Therapeutics, Inc. |
Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
|
|
BRPI1015295A2
(pt)
|
2009-04-20 |
2016-05-31 |
Angiochem Inc |
traamento de câncer de ovário usando um agente anticâncer conjugado a um análogo angiopep-2.
|
|
JP5797191B2
(ja)
|
2009-06-05 |
2015-10-21 |
１３セラピューティクス， インコーポレイテッド |
免疫調節ペプチドおよびその使用
|
|
CA2766537A1
(en)
|
2009-07-02 |
2011-01-06 |
Angiochem Inc. |
Multimeric peptide conjugates and uses thereof
|
|
KR102182663B1
(ko)
|
2010-05-28 |
2020-11-25 |
사렙타 쎄러퓨틱스, 인코퍼레이티드 |
변형된 서브유니트간 결합 및/또는 말단 그룹을 갖는 올리고뉴클레오타이드 유사체
|
|
WO2012031243A2
(en)
|
2010-09-03 |
2012-03-08 |
Avi Biopharma, Inc. |
dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
|
|
US8580748B2
(en)
|
2011-04-06 |
2013-11-12 |
13Therapeutics, Inc. |
Peptides for the treatment of hearing
|
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
|
BR112014011875B1
(pt)
|
2011-11-18 |
2022-01-04 |
Sarepta Therapeutics, Inc |
Oligonucleotídeos funcionalmente modificados e subunidades dos mesmos
|
|
JP6542662B2
(ja)
|
2012-03-20 |
2019-07-10 |
サレプタ セラピューティクス， インコーポレイテッド |
オリゴヌクレオチドアナログのボロン酸結合体
|
|
GB201210358D0
(en)
*
|
2012-06-12 |
2012-07-25 |
Polytherics Ltd |
Complexes
|
|
AU2013302270A1
(en)
|
2012-08-14 |
2015-03-26 |
Angiochem Inc. |
Peptide-dendrimer conjugates and uses thereof
|
|
MA41795A
(fr)
|
2015-03-18 |
2018-01-23 |
Sarepta Therapeutics Inc |
Exclusion d'un exon induite par des composés antisens dans la myostatine
|
|
US11020417B2
(en)
|
2015-06-04 |
2021-06-01 |
Sarepta Therapeutics, Inc |
Methods and compounds for treatment of lymphocyte-related diseases and conditions
|
|
WO2016205367A1
(en)
|
2015-06-15 |
2016-12-22 |
Angiochem Inc. |
Methods for the treatment of leptomeningeal carcinomatosis
|
|
WO2017062699A1
(en)
*
|
2015-10-07 |
2017-04-13 |
Cormedix Inc. |
Skin-penetrating formulation of taurolidine
|